Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
W
330350
vs
K
KOSPI 200
Over the past 12 months, Withus Pharmaceutical Co Ltd has underperformed KOSPI 200, delivering a return of +3% compared to KOSPI 200's +112% growth.
Stocks Performance
330350 vs KOSPI 200
Performance Gap
330350 vs KOSPI 200
Performance By Year
330350 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Withus Pharmaceutical Co Ltd
Glance View
Withus Pharmaceutical is a South Korean drug company that develops, manufactures, and sells medicines. Its products are sold through the healthcare supply chain, mainly to hospitals, clinics, pharmacies, and distributors that buy medicines for patients and consumers. The company makes money the traditional pharma way: it sells prescription drugs and other medical products into the market, then earns revenue when wholesalers, pharmacies, and medical institutions place repeat orders. Its business depends on building a portfolio of branded medicines and maintaining relationships with prescribers and distributors. What makes this business model different is that it sits close to the point where medical products move from manufacturer to patient. That means its success depends less on a single consumer brand and more on product approvals, doctor and pharmacist trust, and steady demand for treatments that people need over and over again.